Stephanie Graff named director of breast oncology at Lifespan Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Stephanie Graff was named director of breast oncology at the Lifespan Cancer Institute.

Graff is board certified in medical oncology, hematology, and internal medicine. 

Graff comes to Lifespan from the Sarah Cannon Cancer Center of HCA Healthcare, where she was director of the breast program for HCA Midwest in Kansas City and both the National Breast Lead and Associate Director of Breast Cancer Research for the entire Sarah Cannon network.

She is the medical director of the Dr. Susan Love Foundation for Breast Cancer Research. 

Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login